Total Payments
$164,663
2024 Payments
$33,996
Companies
24
Transactions
346
Payment Breakdown by Category
Other$132,644 (80.6%)
Travel$16,784 (10.2%)
Consulting$9,040 (5.5%)
Food & Beverage$6,192 (3.8%)
Education$3.25 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $115,556 | 71 | 70.2% |
| Travel and Lodging | $16,784 | 85 | 10.2% |
| Honoraria | $10,588 | 8 | 6.4% |
| Consulting Fee | $9,040 | 7 | 5.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $6,500 | 5 | 3.9% |
| Food and Beverage | $6,192 | 169 | 3.8% |
| Education | $3.25 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $84,581 | 147 | $0 (2024) |
| EISAI INC. | $55,112 | 84 | $0 (2022) |
| Lundbeck LLC | $12,318 | 32 | $0 (2018) |
| LivaNova USA, Inc. | $10,360 | 35 | $0 (2020) |
| Cyberonics, Inc. | $1,323 | 9 | $0 (2017) |
| Greenwich Biosciences, Inc. | $215.04 | 5 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $175.09 | 13 | $0 (2018) |
| SK Life Science, Inc. | $154.47 | 2 | $0 (2024) |
| BioMarin Pharmaceutical Inc. | $70.13 | 1 | $0 (2018) |
| PTC Therapeutics, Inc. | $58.75 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33,996 | 41 | UCB, Inc. ($33,787) |
| 2023 | $23,380 | 45 | UCB, Inc. ($23,346) |
| 2022 | $17,149 | 34 | UCB, Inc. ($15,738) |
| 2021 | $13,091 | 23 | UCB, Inc. ($6,866) |
| 2020 | $11,735 | 22 | Eisai Inc. ($9,056) |
| 2019 | $19,030 | 45 | EISAI INC. ($16,409) |
| 2018 | $26,450 | 66 | Eisai Inc. ($17,904) |
| 2017 | $19,832 | 70 | Lundbeck LLC ($7,309) |
All Payment Transactions
346 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Neurology | ||||||
| 10/08/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.05 | General |
| 09/04/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Neurology | ||||||
| 08/28/2024 | Pyros Pharmaceuticals, Inc. | VIGPODER (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: PEDIATRIC NEUROLOGY | ||||||
| 08/27/2024 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,100.00 | General |
| Category: Neurology | ||||||
| 08/27/2024 | UCB, Inc. | Nayzilam (Drug) | Travel and Lodging | Cash or cash equivalent | $169.51 | General |
| Category: Neurology | ||||||
| 08/20/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Neurology | ||||||
| 08/15/2024 | UCB, Inc. | Nayzilam (Drug) | Travel and Lodging | In-kind items and services | $200.36 | General |
| Category: Neurology | ||||||
| 08/15/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $97.00 | General |
| Category: Neurology | ||||||
| 08/13/2024 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,100.00 | General |
| Category: Neurology | ||||||
| 08/13/2024 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Neurology | ||||||
| 08/13/2024 | UCB, Inc. | Nayzilam (Drug) | Travel and Lodging | Cash or cash equivalent | $113.23 | General |
| Category: Neurology | ||||||
| 07/26/2024 | UCB, Inc. | Nayzilam (Drug) | Travel and Lodging | In-kind items and services | $40.00 | General |
| Category: Neurology | ||||||
| 07/11/2024 | UCB, Inc. | Nayzilam (Drug) | Travel and Lodging | In-kind items and services | $211.11 | General |
| Category: Neurology | ||||||
| 07/11/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 07/10/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $123.42 | General |
| Category: Neurology | ||||||
| 07/02/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,100.00 | General |
| Category: Neurology | ||||||
| 07/02/2024 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Neurology | ||||||
| 07/02/2024 | UCB, Inc. | Nayzilam (Drug) | Travel and Lodging | Cash or cash equivalent | $74.28 | General |
| Category: Neurology | ||||||
| 07/02/2024 | UCB, Inc. | Nayzilam (Drug) | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: Neurology | ||||||
| 07/02/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: Neurology | ||||||
| 07/02/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | Cash or cash equivalent | $13.90 | General |
| Category: Neurology | ||||||
| 06/24/2024 | Pyros Pharmaceuticals, Inc. | VIGPODER (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: PEDIATRIC NEUROLOGY | ||||||
| 06/13/2024 | UCB, Inc. | Nayzilam (Drug) | Travel and Lodging | In-kind items and services | $40.00 | General |
| Category: Neurology | ||||||
| 05/29/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Neurology | ||||||
About Dr. John Ingram, M.D
Dr. John Ingram, M.D is a Pediatrics healthcare provider based in Jackson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2007. The National Provider Identifier (NPI) number assigned to this provider is 1134319619.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Ingram, M.D has received a total of $164,663 in payments from pharmaceutical and medical device companies, with $33,996 received in 2024. These payments were reported across 346 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($115,556).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Neurology with Special Qualifications in Child Neurology
- Location Jackson, MS
- Active Since 07/31/2007
- Last Updated 02/04/2014
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1134319619
Products in Payments
- Briviact (Drug) $55,164
- Fycompa (Drug) $55,112
- Nayzilam (Drug) $22,975
- ONFI (Drug) $12,148
- VNS Therapy (Device) $11,683
- Vimpat (Drug) $2,290
- Fintepla (Drug) $288.00
- Epidiolex (Drug) $215.04
- APTIOM (Drug) $175.09
- SABRIL (Drug) $169.80
- XCOPRI (Drug) $123.42
- Brineura (Biological) $70.13
- EMFLAZA (Drug) $58.75
- VIGPODER (Drug) $54.04
- ACTHAR (Biological) $24.27
- EPIDIOLEX (Drug) $21.69
- VYVANSE (Drug) $20.52
- DAYBUE (Drug) $20.45
- DALVANCE (Drug) $19.79
- GABLOFEN (Drug) $19.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Jackson
Dr. Dereck Davis
Pediatrics — Payments: $19,952
Pediatrics $19,952
Mrs. Tami Brooks, M.d, M.D
Pediatrics — Payments: $14,840
Pediatrics $14,840
Lucas Wilson
Pediatrics — Payments: $11,620
Pediatrics $11,620
Dr. David Josey, M.d, M.D
Pediatrics — Payments: $10,018
Pediatrics $10,018
Barbara Saunders, Do, DO
Pediatrics — Payments: $7,120
Pediatrics $7,120
Colette Parker, M.d, M.D
Pediatrics — Payments: $6,341
Pediatrics $6,341